Hdg: High cost patented drugs a crippling blow to those with rare diseases

On World Rare Diseases Day, India’s focus is on the high cost of treatments for rare diseases due to monopoly drug pricing. The National Policy for Rare Diseases aims to lower costs and promote local drug manufacturing. A patient’s court battle for affordable SMA treatment highlights the need for policy implementation and transparent drug pricing.